CClinicalTrials.gg
CompletedNCT022790694rollUpdated Oct 25, 2019

4-point vs 4-roll Canne as Walking Aids After Stroke

An interventional study of 4-roll canne in Stroke, sponsored by University Hospital of Mont-Godinne. Completed at 1 site in Belgium. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2019-10-25.

Sponsored by University Hospital of Mont-Godinne · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Stroke patients frequently necessitate walking aids such as 4-point canne. However, the 4-point canne has to be lifted by the patient which limited gait speed. The adjunction of small wheel below the 4 point of the canne (4-roll) gives the possibility to the patient to walk without having to lift the canne as it will roll over the ground.

The aim of our study is to compare gait parameters (gait speed and energy cost) with a classical 4-point canne and with 4-roll canne.

Read the detailed description

Stroke patients frequently need walking aids such as 4-point canne. However, the 4-point canne has to be lifted by the patient which limited gait speed. The adjunction of small wheel below the 4 point of the canne (4-roll) gives the possibility to the patient to walk without having to lift the canne as it will roll over the ground.

OBJECTIVE To compare the gait parameters with a 4-point canne and with a 4-roll canne METHODS The investigators will recruited stroke patients who necessitate 4 point-canne as walking aids. A 10 meters walking test, a 6 minutes walking test, an estimated energy cost and a patient's satisfaction will be monitored with a 4-point canne (day 1) and with a 4-roll canne (day 2) in a cross-over study. The first tested device will be randomized.

PERSPECTIVE The investigators hope to demonstrate that a 4-roll canne makes possible to walk faster in a safe way after stroke

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • stroke
  • walking
  • rehabilitation
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 32 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Hospital of Mont-Godinne is the lead sponsor of 24 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • post stroke patient
  • able to walk 10 meters

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment limiting walking capacities
  • need support when walking
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
32 participants (actual)

Study arms

  • Active comparator
    4-point canne

    Stroke patients walk with 4-point canne

    Device: 4-roll canne

  • Experimental
    4-roll canne

    Stroke patients walk with 4-roll canne

    Device: 4-roll canne

Interventions

  • Device4-roll canne
06

What researchers measure

Primary outcomes

  1. 10 meters walking test at spontaneous speed

    Time frame: 2 days

Secondary outcomes

  1. 10 meters walking test at fast speed

    Time frame: 2 days

  2. 6 minutes walking test

    Time frame: 2 days

  3. Borg scale for perceived exertion

    Time frame: 2 days

  4. Visual analogic scale for personal satisfaction

    Time frame: 2 days

  5. Energy cost

    Extrapolated from heart rate while walking

    Time frame: 2 days

07

Study locations

1 site
  • Deltombe Thierry
    Yvoir, 5530, Belgium
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02279069
Lead sponsor
University Hospital of Mont-Godinne
Responsible party
Deltombe Thierry (Professeur Clinique, University Hospital of Mont-Godinne) — Principal investigator
First posted
Oct 30, 2014
Start date
Oct 2014
Primary completion
Jan 2017
Completion
Mar 2017
Last update
Oct 25, 2019

Study contacts

Thierry Deltombe, MD
principal investigator · CHU Dinant Godinne / UcL Namur
Geoffroy Dellicour, PT
principal investigator · Centre Neurologique William Lennox Ottignies

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion